Form D · Biotechnology

Integrated Diagnostics, Inc.

Seattle, WA · CIK 0001458503

Offering snapshot reported Dec 8, 2016 · SEC filing

Reported sold
$6.1M
Indefinite offering
Investors reported
6
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 23, 2016
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 8, 2016Initial$6,099,999No comparison6SEC filing
May 7, 2014Initial$31,714,889No comparison6SEC filing
Sep 15, 2009Initial$7,525,000No comparison4SEC filing
Mar 13, 2009Initial$0No comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-275891

Source: Form D, filed Dec 8, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
David Barker Director
John Bencich Executive
Greg Critchfield Director
Stephen Davis Executive
Kenneth Fang Executive
David Galas Director
James Garner Executive
James Heath Director
Leroy Hood Director
Paul Kearney Executive
Michael Liang Director
Albert Luderer Director, Executive
Jay Moyes Director
Arnold Oronsky Director
Douglas Sanders Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
219 Terry Avenue North, Suite 100
Seattle, WA, 98109